MedTrace Logo

Determination of Biomarkers of Exposure and Biomarkers of Potential Harm in Asian Adult Cigarette Smokers

NCT02103751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1069

Last updated 2019-11-07

No results posted yet for this study

Summary

The purpose of this study is to determine biomarkers of exposure to Harmful and Potentially Harmful Constituents (HPHCs) in Cigarette Smoke and cardiovascular-related biomarkers in smokers and non smokers.

Conditions

  • Smoking
  • Healthy

Sponsors & Collaborators

  • Philip Morris Products S.A.

    lead INDUSTRY

Principal Investigators

  • Prof. Tomoko Hasunuma, MD · Kitasato University, Tokyo, Japan

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2007-12-31
Completion
2008-02-29

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103751 on ClinicalTrials.gov